Medicine

Obstetrics Oncology at IgMin Research | Medicine Group

Our mission is to foster interdisciplinary dialogue and accelerate the advancement of knowledge across a wide spectrum of scientific domains.

About

Obstetrics Oncology is a specialized field at the intersection of obstetrics (pregnancy care) and oncology (cancer care). It focuses on managing and providing medical care to pregnant individuals who are diagnosed with cancer or have a history of cancer. This unique subspecialty requires expertise in balancing the well-being of both the pregnant person and their unborn child while addressing cancer treatment needs.

The study of Obstetrics Oncology involves understanding the complexities of cancer treatment options, potential risks to the fetus, and the delicate balance between maternal health and fetal development. Obstetrics Oncologists collaborate closely with oncology teams to devise personalized treatment plans that optimize cancer management while considering the safety of the pregnancy. Their goal is to provide the best possible outcomes for both the mother and the baby.

  • Cancer Diagnosis and Staging during Pregnancy
  • Pregnancy-Associated Cancers
  • Treatment Decision-Making for Pregnant Cancer Patients
  • Chemotherapy
  • Radiation
  • and Surgery during Pregnancy
  • Fetal Monitoring and Safety Measures
  • Hormonal Therapies and Fertility Preservation
  • Multidisciplinary Cancer Care Teams
  • High-Risk Pregnancy Management
  • Maternal-Fetal Health Optimization
  • Postpartum Oncologic Follow-Up
  • Ethical Considerations in Obstetrics Oncology
  • Patient Counseling and Support
  • Pregnancy and Cancer Research
  • Obstetrics Oncology Education and Training
  • Collaborative Research Initiatives
  • Tele-obstetrics Oncology
  • Reproductive Health and Family Planning in Cancer Patients
  • Obstetrics Oncology Innovations
  • Public Health Initiatives in Obstetrics Oncology
  • Obstetrics Oncology Continual Medical Education

Medicine Group (2)

Review Article Article ID: igmin160
Cite

Open Access Policy refers to a set of principles and guidelines aimed at providing unrestricted access to scholarly research and literature. It promotes the free availability and unrestricted use of research outputs, enabling researchers, students, and the general public to access, read, download, and distribute scholarly articles without financial or legal barriers. In this response, I will provide you with an overview of the history and latest resolutions related to Open Access Policy.

Breast Cancer: The Road to a Personalized Prevention
by Zaira Grattagliano and Asia Grattagliano

Breast cancer is the most common type of cancer in women worldwide. It can be spread when cancer cells get into the blood or lymph system and then are carried to other parts of the body. As it is one of the leading causes of death among women, this study aims to identify the most relevant risk factors for breast cancer... through several prevention methods for early detection. The social impact of breast cancer is so strong that the World Health Organization (WHO) has established 19 October as International Breast Cancer Day. The pink ribbon is the symbol of this important day worldwide. The objective is precisely to raise awareness among the population about the disease and promote access to timely and effective diagnoses, checks, and treatments.Good prevention should be carried out through behavior or lifestyle modifications (e.g., diet, physical activity, alcohol limitation, etc.). Although, certain risk factors cannot be modified (e.g., aging, family history). Screenings are a fundamental tool to deal with breast cancer, even if sometimes they are not enough as in the case of interval cancers or in cases of particularly ambiguous presentation. Worldwide organizations recommend screening by means of ultrasound, mammography, and magnetic resonance, with appropriate follow-up for an abnormal screening test. To avoid overdiagnosis and overtreatment that can lead to long-term complications and false negatives, these screening differs by recommended ages and frequency. Identification of women at risk for BRCA1 and BRCA2 mutations is also recommended with a referral for genetic testing and, in the presence of dubious lesions, a biopsy is needed. In order to fight this disease, is important to act on time, so, information is fundamental. First of all, the female population should be conscious of risk factors and of the importance of breast examinations from a young age, lastly, they should be aware of the possibility of joining programs of free screening.

Clinical Medicine Obstetrics OncologyGenetics
Case Report Article ID: igmin154
Cite

Open Access Policy refers to a set of principles and guidelines aimed at providing unrestricted access to scholarly research and literature. It promotes the free availability and unrestricted use of research outputs, enabling researchers, students, and the general public to access, read, download, and distribute scholarly articles without financial or legal barriers. In this response, I will provide you with an overview of the history and latest resolutions related to Open Access Policy.

A Rare Case of Recurrent Vulvovaginal Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP)
by Sakshi Zawar, Priyanka Chaudhari, Viraj Borgaonkar and Utpal Gaikwad

Smooth muscle tumours are the most common mesenchymal tumors of the vulva and vagina, yet their infrequency is demonstrated by the prevalence of published reports as individual cases or small case series.This article reports a case of a 42-year-old woman who presented with apparently recurrent vulvovaginal leiomyoma an...d a past history of surgical excisions. Histopathology revealed Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP).

Pathology Obstetrics OncologyGynecology